1. Home
  2. RNAC vs APYX Comparison

RNAC vs APYX Comparison

Compare RNAC & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

N/A

Current Price

$8.12

Market Cap

217.1M

Sector

Health Care

ML Signal

N/A

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

N/A

Current Price

$3.96

Market Cap

128.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RNAC
APYX
Founded
2007
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
217.1M
128.0M
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
RNAC
APYX
Price
$8.12
$3.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$35.00
$6.67
AVG Volume (30 Days)
176.5K
70.1K
Earning Date
06-15-2026
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
19.40
EPS
N/A
N/A
Revenue
$2,797,000.00
N/A
Revenue This Year
N/A
$9.36
Revenue Next Year
$26.02
$6.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.98
$0.83
52 Week High
$17.42
$4.50

Technical Indicators

Market Signals
Indicator
RNAC
APYX
Relative Strength Index (RSI) 56.52 59.90
Support Level $6.41 $3.82
Resistance Level $10.49 $4.40
Average True Range (ATR) 0.82 0.21
MACD 0.13 0.03
Stochastic Oscillator 61.17 86.87

Price Performance

Historical Comparison
RNAC
APYX

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Share on Social Networks: